Structural Pharmaceutics LLC is categorized under Analytical Instruments in Tucson, AZ and active since 2006.
Structural Pharmaceutics LLC was established in 2006, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Analytical Instruments business, which does work in the B2B market, and is classified as a Analytical Instruments, under code number 334516 by the NAICS.
If you are seeking more information, feel free to contact Norman P Soloway at the company’s single location by writing to 3450 East Sunrise Drive # 140, Tucson, Arizona AZ 85718 or by phoning (520) 882-7623. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Structural Pharmaceutics LLC |
| Contact Person: | Norman P Soloway |
| Address: | 3450 East Sunrise Drive # 140, Tucson, Arizona 85718 |
| Phone Number: | (520) 882-7623 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Analytical Instruments |
| SIC Code: | 3826 |
| NAICS Code: | 334516 |
| Share This Business: |
Structural Pharmaceutics LLC was started in 2006 to provide professional Analytical Instruments under the SIC code 3826 and NAICS code 334516. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Norman P Soloway for inquiries that concern Structural Pharmaceutics LLC by calling the company number (520) 882-7623, as your correspondence is most welcome. Additionally, the physical location of the single location of Structural Pharmaceutics LLC can be found at the coordinates 32.320417,-110.919286 as well as the street address 3450 East Sunrise Drive # 140 in Tucson, Arizona 85718.
For its online presence, you may visit Structural Pharmaceutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.